Adverse Effects Profile of Dicycloplatin (DCP) Offers Chemotherapeutic Advantage Over Cisplatin and Carboplatin.
Yu JJ, Hogan T, Morley C, Crigger C, Jiao S, Williams DJ, Salkini MW, Yang X, Liang X, Yan B, Cecil C, Winn AC, Zheng J, Guo YI, Jiang BH, Washington IM.
Yu JJ, et al.
Anticancer Res. 2019 Aug;39(8):4455-4462. doi: 10.21873/anticanres.13618.
Anticancer Res. 2019.
PMID: 31366544